UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

Tesla’s European joyride is skidding hard in April, with sales nose-diving across key markets like Sweden, Denmark, and ...

The Manufacturers Life Insurance Company reduced its Home Depot holdings by 4.7% in Q4, selling 38,498 shares. This left the ...

Apple shares dipped nearly 3% after CEO Tim Cook revealed a looming $900 million tariff toll this quarter and scaled down ...

Merck & Co. is caught in the middle of Wall Street's version of a group chat disagreement. Analysts gave it a “Moderate Buy” ...

Southern Copper just got a lukewarm upgrade from HSBC Global Res, shifting from “moderate sell” to “hold”—which is basically ...

Alphabet, despite a tech giant glow-up, has underperformed the broader market, dropping 16.1% year-to-date while others ...

JPMorgan Chase strutted into Q1 2025 with a financial performance that deserves a standing ovation and maybe a bonus or two.

Amazon has responded to tariff concerns by leaning on its third-party sellers, who bulked up inventory to maintain pricing ...

Walmart saw a small trim in its holdings by Beacon Pointe Advisors, who offloaded 22,795 shares in Q4, though the retailer ...

California State Teachers Retirement System reduced its Exxon Mobil holdings by 9.1% in Q4, selling 532,382 shares, yet it ...